ErlySign – Saliva-Based Early Oral Cancer Detection Kit

Pioneering the Future of Early Cancer Detection

Revolutionizing Early Detection for a Healthier Tomorrow

Pioneering the Future of Early Cancer Detection

Revolutionizing Early Detection for a Healthier Tomorrow

Innovating Health, Empowering Lives

Driven by innovation, guided by science ErlySign is transforming early disease detection with cutting edge, non-invasive detection

Saving Lives Early

Pioneering Early Detection

Innovating Healthcare Solutions

Future of Detection

ErlySign is building a future where detection are fast, pain-free, and accessible to all.

ErlySign Oral Cancer Detection Kit

Detect Oral Cancer Before It’s Too Late

50%

More affordable than Biopsy

Cost advantage of our kit

98%

Detection Accuracy

Clinically tested precision level

15-Min

Test Results

Quick, lab-free diagnosis

How It Works ?

Our innovative testing process is designed for accuracy, ease, and early detection

Easy Sample Collection

Collect your sample in minutes whether saliva, blood, or another non-invasive method without the need for complex procedures.

Advanced Lab Analysis

your sample is analyzed with high precision to detect early signs of health conditions.

Fast & Reliable Results

No waiting for weeks—receive your verified test results digitally, allowing for quick and informed decisions about your health.

Consult Experts, Take Action

If your results indicate a risk, connect with top oncologists and healthcare providers for expert guidance on the next steps.

Why Partner with us ?

Partner with us to bring cutting edge, non invasive early detection to more people.

Life-Saving Innovation

Non-invasive, portable, fast testing.

Plug-and-Play Simplicity

No large machines or complex procedures

Scalable for Everyone

Designed for hospitals, labs, and clinics—urban or rural

Impact at Scale

can help save 1 million+ lives annually

Who we partner with ?

Hospitals

Enable fast cancer screenings and enhance institutional preventive care delivery.

60%

increase in early stage detection

Diagnostic labs

Offer quick testing services, attract customers, and boost foot traffic.

3x

rise in repeat visits

Dental clinics

Detect early, save lives faster, and elevate patient care standards.

80%

patients prefer instant screening

We are backed by

Awards & Recognition

Recognized globally for redefining early cancer diagnostics.

GHP Biotechnology awards 2022

Best early stage cancer diagnostics startup – South Asia

TV9 Marathi news channel Interview

Talked on the importance of early stage cancer detection

HealthTech Breakthrough Award 2024

ErlySign Is Revolutionizing Oral Cancer Detection with Saliva

HealthTech Breakthrough Award 2024

ErlySign Is Revolutionizing Oral Cancer Detection with Saliva

Latest News & Research

Erlysign Secures ₹16 cr for advancing saliva-based cancer detection tech

Collect your sample in minutes—whether saliva, blood, or another non-invasive method—without the need for complex procedures…..

ErlySign raises Rs 16 Cr in Pre-Series A funding round to launch oral ...

Mumbai-based startup CURO Biosciences Private Limited, also known as ErlySign, has secured Rs 16 crore in pre-Series A funding from renowned investor Ashish Kacholia.

Ashish Kacholia invests in this healthtech startup

ErlySign is India’s first-ever salivary biomarker-based test which can identify pre-cancerous conditions much before visible symptoms emerge, revolutionising proactive healthcare and early diagnosis.

ErlySign raises Rs 16 crore from Ashish Kacholia to advance oral ...

ErlySign, formally known as CURO Biosciences, has raised Rs 16 crore in a pre-Series A funding round led by veteran investor Ashish Kacholia.

CURO Biosciences Secures ₹16 cr for advancing saliva-based cancer...

ErlySign’s innovation is a biomarker-based test kit capable of detecting oral precancerous conditions within just 15 minutes using a simple, non-invasive saliva sample

ErlySign raises $1.8 Mn in pre-Series A round from Ashish Kacholia

Healthtech startup ErlySign has raised Rs 16 crore ($1.8 million) in its pre-Series A round from Ashish Kacholia.

ErlySign Bags INR 16 Cr To Develop Cancer Diagnostic Solutions

The fresh proceeds will be deployed in clinical trials, securing CDSCO (Central Drugs Standard Control Organisation) approvals, and bringing ErlySign’s oral cancer detection kit to market

CDSCO approves ErlySign’s oral cancer detection technology

Following a comprehensive year-long investigation and based on in-house validation data of 150 test samples, the Indian Regulatory Authority CDSCO has granted permission

ERLYSIGN gets CDSCO approval for large-scale clinical trials

ErlySign, a pioneering biotech start-up located in Nagpur, announces a significant milestone in the fight against cancer with approval from the Indian regulatory agency

Erly Sign: Transforming Diagnostic Industry Via Early Stage Detection

Oral cancer is one of the top three cancer types in men and women in Southeast Asia. And India is known as the world’s capital of oral cancer. According to the Global Adult Tobacco …

Making a difference in the lives of cancer patients

Cancer is devastating for many. With World Cancer Day just gone by, we bring you beacons of hope that are trying to make a difference in the lives of cancer patients.

World Cancer Day: Latest advancements in the early cancer...

Cancer is a complex disease of worldwide concern. Along with an improvement in outcomes, early and sensitive detection of cancer and cancer biomarkers can facilitate an understanding of cancer progression

How Erly Sign As A Biotech Startup Is Changing The Face of Cancer...

In India, cancer is the most common cause of death in adults. While cancer can affect any part of the body, oral cancer is among the top three common types in the country.

This diagnostics startup helps screen patients for oral cancer risk with...

Nagpur-based diagnostics startup Erlysign’s first test kit, an easy and quick way to screen for oral cancer through a saliva sample, is undergoing clinical trials….

89 Top Indian Medical Device Companies and Startups of 2021

This article showcases our top picks for the best Indian based Medical Device companies. These startups and companies are taking a variety of approaches to innovating…

Lumos Health Accelerator onboards startups in early cancer detection...

Lumos, a premier Healthcare speed scaling program, today announced the addition of Onward Assist and ErlySign to its speed scaling program. The …

Featured In

ErlySign has been showcased by top healthcare publications, research institutions, and media outlets for its groundbreaking innovations in detection

What Our Partners & Experts Say

From patients to healthcare professionals, hear how ErlySign is making a difference in lives worldwide.

ErlySign’s oral cancer kit is a game-changer

Implementing ErlySign’s oral cancer detection kit has transformed our early diagnosis approach. It’s fast, cost effective, and incredibly easy for our team to adopt

60%

Increase in Early Detection Within 6 months of adoption

Dr. Neha Verma

Sunrise Multispeciality Hospital

ErlySign’s oral cancer kit is a game-changer

Implementing ErlySign’s oral cancer detection kit has transformed our early diagnosis approach. It’s fast, cost effective, and incredibly easy for our team to adopt

60%

Increase in Early Detection Within 6 months of adoption

Dr. Neha Verma

Sunrise Multispeciality Hospital

ErlySign’s oral cancer kit is a game-changer

Implementing ErlySign’s oral cancer detection kit has transformed our early diagnosis approach. It’s fast, cost effective, and incredibly easy for our team to adopt

60%

Increase in Early Detection Within 6 months of adoption

Dr. Neha Verma

Sunrise Multispeciality Hospital

Let’s Shape the Future of Early Detection Together.

Whether you’re a hospital, doctor, or distributor, we’d love to collaborate and bring early detection to more people.

98.04%

Reliable, lab-verified results you can trust.

500+

Hospitals, clinics, and doctors rely on us.

1 Million+

Empowering people with early diagnosis worldwide.

15-Mins

Fast, non-invasive testing for early detection.

Pioneering the Future of Early Cancer Detection

Pioneering the Future of Early Cancer Detection

Innovating Health, Empowering Lives

Future of Detection

ErlySign Oral Cancer Detection Kit

Detect Oral Cancer Before It’s Too Late

50%

More affordable than Biopsy

98%

Detection Accuracy

15-Min

Test Results

How It Works ?

Why Partner with us ?

Who we partner with ?

Hospitals

60%

Diagnostic labs

3x

Dental clinics

80%

We are backed by

Awards & Recognition

Latest News & Research

ErlySign raises Rs 16 Cr in Pre-Series A funding round to launch oral ...

Ashish Kacholia invests in this healthtech startup

ErlySign raises Rs 16 crore from Ashish Kacholia to advance oral ...

CURO Biosciences Secures ₹16 cr for advancing saliva-based cancer...

ErlySign raises $1.8 Mn in pre-Series A round from Ashish Kacholia

ErlySign Bags INR 16 Cr To Develop Cancer Diagnostic Solutions

CDSCO approves ErlySign’s oral cancer detection technology

ERLYSIGN gets CDSCO approval for large-scale clinical trials

Erly Sign: Transforming Diagnostic Industry Via Early Stage Detection

Making a difference in the lives of cancer patients

World Cancer Day: Latest advancements in the early cancer...

How Erly Sign As A Biotech Startup Is Changing The Face of Cancer...

This diagnostics startup helps screen patients for oral cancer risk with...

89 Top Indian Medical Device Companies and Startups of 2021

Lumos Health Accelerator onboards startups in early cancer detection...

Featured In

What Our Partners & Experts Say

ErlySign’s oral cancer kit is a game-changer

60%

Dr. Neha Verma

ErlySign’s oral cancer kit is a game-changer

60%

Dr. Neha Verma

ErlySign’s oral cancer kit is a game-changer

60%

Dr. Neha Verma

Let’s Shape the Future of Early Detection Together.

98.04%

500+

1 Million+

15-Mins

Stay Updated with ErlySign

Get Started with ErlySign